Phase I trial comparing the bioavailability of three abuse-deterrent levophanol extended-release formulations with the immediate release formulation.

Trial Profile

Phase I trial comparing the bioavailability of three abuse-deterrent levophanol extended-release formulations with the immediate release formulation.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Sep 2013

At a glance

  • Drugs Levorphanol (Primary)
  • Indications Pain
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 10 Sep 2013 Results published in a Relmada Therapeutics Media Release.
    • 01 Sep 2013 Status changed from not yet recruiting to completed.
    • 06 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top